Juvenile Myelomonocytic Proliferation: A Diagnostic Dilemma

Authors

  • Shital Shankar Harne Department of Pathology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400022, Maharashtra, India
  • Rakesh Tukaram Shedge Department of Pathology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400022, Maharashtra, India
  • Sayali Keshrao Pote Department of Pathology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400022, Maharashtra, India

DOI:

https://doi.org/10.21276/apalm.3933

Keywords:

juvenile myelomonocytic proliferation, paediatric leukemia, myelomonocytic proliferation

Abstract

This article reports a case of juvenile myelomonocytic proliferation. Juvenile Myelomonocytic Proliferation is an entity that includes many disorders like reactive myelomonocytic proliferation after viral sequelae, myelomonocytic proliferation associated with genetic syndromes like Noonan's syndrome and leukaemia like juvenile myelomonocytic proliferation. It mainly affects paediatric population. This case reports a similar case in a 4 year old female child who presented with generalised weakness and distention of abdomen since 15 days. She was referred from a private hospital as she was not responding to symptomatic management. On examination, patient in our centre had pallor, hepatosplenomegaly and inguinal lymphadenopathy. A complete blood count revealed Haemoglobin-5.5gm/dl, TLC-1,77,000/ul, Platelets-14000/ul. Peripheral smear with flow cytometry was reported as juvenile myelomonocytic proliferation. The patient did not have any phenotypic findings that could suggest syndromic associations. Based on above laboratory findings this was thought to be a case of juvenile myelomonocytic leukaemia and patient was given two units of Packed red cells (PRCs) for improving haemoglobin level and tablet hydroxyurea and allopurinol and IV Rasburicase with the intent of cytoreduction. Unfortunately, patient deteriorated clinically and hence further workup was not possible as the patient succumbed to death due to haemorrhagic shock following disseminated intravascular coagulation. Hence a detailed and timely evaluation of juvenile myelomonocytic proliferation is paramount for accurate diagnosis and appropriate management.

References

1. Lanzkowsky P, Lipton JM, Fish JD. Lanzkowsky's Manual of Paediatric Haematology and Oncology. 6th edition. London: Elsevier; 2016.

2. Choudhary et al. A case report of juvenile myelomonocytic leukemia in a child: An uncommon presentation. International Journal of Pharmaceutical and Clinical Research 2024; 16(12): 505-508.

3. Ahl Cheikh Errim et al. Juvenile myelomonocytic leukemia a case report. Sch J Med Case Dec, 2024; 12(12): 2184-2187.

4. Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leukemia Research 2009; 33(3): 355-362.

5. International Agency for Research on Cancer. WHO Classification of Tumours of Haematolymphoid Tumours. 5th ed., Vol. 2. World Health Organization; 2022.

6. Niemeyer CM. Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases. Blood 1997; 89: 3534-3543.

7. Benessahraoui M, Aubin F, Paratte F, Plouvier E, Humbert P. Leucémie myélomonocytaire juvénile, xanthomes neurofibromatose de type 1. Archives de Pédiatrie 2003; 10(10): 891-894.

8. Emanuel PD. Myelodysplasia and myeloproliferative disorders in childhood: an update. British Journal of Haematology 1999; 105(4): 852-863.

9. Busque L, Gilliland DG, Prchal JT, et al. Clonality in juvenile chronic myelogenous leukemia. Blood 1995; 85: 21-30.

10. Olk-Batz C, Poetsch AR, Nöllke P, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 2011; 117(18).

11. Kang HJ, Shin HY, Choi HS, Ahn HS. Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML). Leukemia Research 2004; 28(2).

12. Locatelli F, Crotta A, Ruggeri A, et al. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood 2013; 122(12): 2135-2141.

Downloads

Published

15-10-2026

Issue

Section

Case Report / Case Series

How to Cite

1.
Juvenile Myelomonocytic Proliferation: A Diagnostic Dilemma. Ann of Pathol and Lab Med [Internet]. 2026 Oct. 15 [cited 2026 Oct. 16];13(10):C257-C260. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3933